Hwaseong, South Korea

Chang Sang Moon

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Boditechmed Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chang Sang Moon. Retrieved from https://idiyas.com/inventor/chang-sang-moon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chang Sang Moon: Innovator in Glycated Hemoglobin Measurement

Introduction

Chang Sang Moon is a notable inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of medical technology, particularly in the measurement of glycated hemoglobin, which is crucial for diabetes management.

Latest Patents

Chang Sang Moon holds a patent for an "Apparatus and method for measuring glycated hemoglobin." This innovative apparatus includes a cartridge designed to receive blood and a variety of chemicals. It features a rotating tray that allows for the cartridge to be rotated, a driver with a nozzle that moves vertically, and a measurement unit positioned above the cartridge to assess the glycated hemoglobin levels in the blood. The driver is capable of sucking in blood, chemicals, or a mixed solution, facilitating a chemical treatment process that enhances the accuracy of the measurement.

Career Highlights

Chang Sang Moon is associated with Boditechmed Inc., a company known for its advancements in medical diagnostics. His work has contributed to the development of more efficient and reliable methods for monitoring blood glucose levels, which is essential for patients with diabetes.

Collaborations

He collaborates with talented colleagues, including Kyung Won Park and Yun Suk Choi, who share his commitment to innovation in medical technology.

Conclusion

Chang Sang Moon's contributions to glycated hemoglobin measurement exemplify the impact of innovative thinking in healthcare. His work continues to influence the field and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…